Streptococcus mitis and S. oralis Lack a Requirement for CdsA, the Enzyme Required for Synthesis of Major Membrane Phospholipids in Bacteria

Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02552-16. doi: 10.1128/AAC.02552-16. Print 2017 May.

Abstract

Synthesis and integrity of the cytoplasmic membrane are fundamental to cellular life. Experimental evolution studies have hinted at unique physiology in the Gram-positive bacteria Streptococcus mitis and S. oralis These organisms commonly cause bacteremia and infectious endocarditis (IE) but are rarely investigated in mechanistic studies of physiology and evolution. Unlike in other Gram-positive pathogens, high-level (MIC ≥ 256 μg/ml) daptomycin resistance rapidly emerges in S. mitis and S. oralis after a single drug exposure. In this study, we found that inactivating mutations in cdsA are associated with high-level daptomycin resistance in S. mitis and S. oralis IE isolates. This is surprising given that cdsA is an essential gene for life in commonly studied model organisms. CdsA is the enzyme responsible for the synthesis of CDP-diacylglycerol, a key intermediate for the biosynthesis of all major phospholipids in prokaryotes and most anionic phospholipids in eukaryotes. Lipidomic analysis by liquid chromatography-mass spectrometry (LC-MS) showed that daptomycin-resistant strains have an accumulation of phosphatidic acid and completely lack phosphatidylglycerol and cardiolipin, two major anionic phospholipids in wild-type strains, confirming the loss of function of CdsA in the daptomycin-resistant strains. To our knowledge, these daptomycin-resistant streptococci represent the first model organisms whose viability is CdsA independent. The distinct membrane compositions resulting from the inactivation of cdsA not only provide novel insights into the mechanisms of daptomycin resistance but also offer unique opportunities to study the physiological functions of major anionic phospholipids in bacteria.

Keywords: Streptococcus; daptomycin; lipidomics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Cardiolipins / metabolism
  • Cytidine Diphosphate Diglycerides / biosynthesis
  • Daptomycin / pharmacology*
  • Drug Resistance, Bacterial / genetics
  • Humans
  • Membrane Lipids / biosynthesis
  • Microbial Sensitivity Tests
  • Nucleotidyltransferases / genetics*
  • Phosphatidic Acids / metabolism
  • Phosphatidylglycerols / metabolism
  • Phospholipids / biosynthesis
  • Streptococcal Infections / microbiology
  • Streptococcal Infections / pathology
  • Streptococcus mitis / drug effects*
  • Streptococcus mitis / genetics*
  • Streptococcus mitis / isolation & purification
  • Streptococcus oralis / drug effects*
  • Streptococcus oralis / genetics*
  • Streptococcus oralis / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Cardiolipins
  • Cytidine Diphosphate Diglycerides
  • Membrane Lipids
  • Phosphatidic Acids
  • Phosphatidylglycerols
  • Phospholipids
  • Nucleotidyltransferases
  • phosphatidate cytidylyltransferase
  • Daptomycin